Dismissed at 13: How diagnostic delays left endometriosis patients in severe pain

At thirteen, she was already taking morphine. Not because of cancer or trauma or any condition doctors expected to find in a child, but because the pain in her abdomen had become so severe that nothing else would touch it. She had been to doctors repeatedly. Each time, she was sent home with the same message: she was too young. Endometriosis, they said, was a disease of adult women. Not teenagers. Certainly not children.

Endometriosis is a condition in which tissue similar to the uterine lining grows outside the uterus, causing inflammation, scarring, and often debilitating pain. It affects millions of people worldwide, but the disease carries a particular burden for young patients: it is routinely missed, dismissed, or attributed to something else entirely. The girl's case is not unusual. Medical professionals, operating from assumptions about who gets sick and when, had constructed an invisible barrier between her symptoms and a diagnosis. Age became a kind of disqualification.

The delay in diagnosis meant years of unmanaged suffering. While doctors deliberated about whether her pain was real or psychosomatic, whether it was normal menstrual cramping or something requiring investigation, she was left to manage the condition on her own terms—which meant morphine, a powerful opioid typically reserved for cancer patients and those in acute crisis. The medication allowed her to function, to attend school, to exist without being completely consumed by pain. But it was a stopgap, not a solution. It treated the symptom while the underlying disease continued to progress unchecked.

The problem runs deeper than one girl's experience. Endometriosis in adolescents is underdiagnosed across healthcare systems, not because the disease is rare in young people but because clinicians are not trained to look for it. Medical education has historically centered endometriosis as an adult condition, something that develops over time, not something that announces itself in a teenager's body. This gap between medical training and clinical reality creates a systematic delay. Young patients report symptoms for months or years before receiving a diagnosis. Some are told their pain is anxiety. Others are prescribed birth control and sent away. A few, like this girl, are given opioids to manage pain that no one has bothered to investigate.

The human cost is substantial and measurable. Adolescents with undiagnosed endometriosis miss school, withdraw from activities, and develop complicated relationships with their own bodies and with medical authority. They learn, early, that their pain will not be believed. They learn that doctors may dismiss them based on age alone. Some develop anxiety or depression as a secondary consequence of chronic untreated pain. The morphine, while necessary in the short term, carries its own risks—dependence, side effects, the psychological weight of being a teenager on a drug typically associated with terminal illness.

What changed for this girl was not a shift in medical understanding but persistence. Eventually, she found a doctor willing to investigate. The diagnosis, when it came, was endometriosis. By then, years had passed. The disease had had time to establish itself, to cause damage that might have been prevented with earlier intervention. She was no longer thirteen. She was older, and her body had paid the price for the delay.

The path forward requires a fundamental reorientation of how medical professionals think about adolescent disease. Endometriosis in teenagers is not rare—it is simply unrecognized. Training programs need to include endometriosis in their curriculum on adolescent gynecology. Clinicians need to be taught that age is not a reliable predictor of who gets this disease. Young people presenting with severe menstrual pain need to be taken seriously, investigated thoroughly, and given access to specialists who understand that endometriosis does not wait until adulthood to begin.